Addiction Treatment Market Size, Share & Industry Analysis, By Type (Alcohol Addiction Treatment, Tobacco/Nicotine Addiction Treatment, Opioid Addiction Treatment), By Drug Type (Bupropion, Varenicline, Acamprosate, Disulfiram, Naltrexone), By Treatment Centers (Residential Treatment Centers, Outpatient Treatment Centers), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy , Online Pharmacy) and Regional Forecast, 2024-2032

Addiction Treatment is the process of medicinal or psychotherapeutic treatment for dependency on psychoactive drugs such as prescription drugs, heroin, cannabis, alcohol, cocaine, and amphetamines. Addiction is a mental disorder which compels someone to repeatedly use substances or engage in behaviors even though they have harmful consequences. Drug treatment is intended to help addicted individuals stop compulsive drug seeking and use. The increase in the prevalence of dependency on psychoactive drugs such as alcohol use disorder, opioid addiction, tobacco, cocaine, marijuana, heroin etc. is driving the market growth. According to the Substance Abuse and Mental Health Services Administration (SAMHSA) 2018, about 32 million Americans aged 12 or older were addicted to drugs. Among them, about 27.6 million people used marijuana, 2.8 million people abused prescription pain relievers, and 1.9 million people used cocaine. Treatment can occur in a variety of settings, take many different forms, and last for different lengths of time. Because drug addiction is typically a chronic disorder characterized by occasional relapses, a short-term, one-time treatment is usually not sufficient. For many, treatment is a long-term process that involves multiple interventions and regular monitoring.

Moreover, drug addiction related deaths are also expected to boost the market growth. According to the National Survey on Drug Use and Health (NSDUH) 2018, from the year 1999 to 2017, more than 700,000 Americans died of drug overdosing. In addition, according to the World Health Organization (WHO), tobacco kills more than 8 million people each year among them more than 7 million of those deaths are the result of direct tobacco use while around 1.2 million are the result of non-smokers being exposed to passive smoke.

However, unwillingness to opt for rehabilitation programs and lack of physical and mental stability of patients during the treatments is obstructing the growth of the market.

Market Segmentation:

Globally, the addiction treatment market can be segmented on the basis of type, drug, treatment centers, distribution channel, and region. Based on the treatment, the market can be segmented into alcohol addiction treatment, tobacco/nicotine addiction treatment, opioid addiction treatment, and others. Based on the drug type, the market can be segmented into bupropion, varenicline, acamprosate, disulfiram, naltrexone, methadone, buprenorphine, nicotine replacement products and others. Based on the treatment centers, the market can be segmented into residential treatment centers, outpatient treatment centers, and inpatient treatment centers. Based on the distribution channel the market can be segmented into retail pharmacy, hospital pharmacy, and online pharmacy. Geographically, the addiction treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Key Players Covered:

Some of the major companies that are present in the addiction treatments systems market are Cipla Inc., Allergan, Alkermes, Pfizer Inc., Orexo AB, GlaxoSmithKline plc., Sandoz International GmbH, Reckitt Benckiser Group plc., Teva Pharmaceutical Industries Ltd., Novartis AG, Indivior PLC and other prominent players.

Key Insights:

• Prevalence of Drug Addictions by Major Countries/Region, 2019


• Introduction of New Products/Approvals (By Major Players)


• Key Industry Developments Mergers, Acquisitions, And Collaborations, 2019

Regional Analysis:

Geographically, the addiction treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North American region is likely to hold the lion’s share of the market and is anticipated to follow the same momentum over the forecast period owing to the increased use of illicit drugs and surge in the quantity of smokers in the and growing concerns regarding health issues for the passive smokers as well as active smokers. Moreover, factors such as well structured reimbursement developed healthcare sector, and legalization of marijuana are also expected to boost the market growth. Europe will follow North America in terms of market share owing to increasing number of tobacco consumers and rising number of alcohol addiction in this region. However, Asia-Pacific will grow with significantly high growth rate due increasing medical tourism, lower therapy cost, escalating number of tobacco and cigarette consumers, the notable rise in a number of therapy centers, and constant government efforts to increase the awareness for addiction in this region.

Segmentation

Addiction Treatment Market Industry Developments

• In November 2018, Sandoz International GmbH (Novartis division) and Pear Therapeutics, Inc., announced the commercial launch of reSET for patients with Substance Use Disorder (SUD)


• In June 2017, Pfizer Inc. collaborated with Eli Lilly and Company for developing non-opioid chronic pain medication called tanezumab and the drug won “fast-track” designation from the Food and Drug Administration.